Self Administered Injectable Drug Delivery Systems: Products, Therapeutics, Markets, Players and Forecasts

Self Administered Injectable Drug Delivery Systems: Products, Therapeutics, Markets, Players and Forecasts

  • June 2017 •
  • Report ID: 4951246 •
  • Format: PDF
Self Administered Injectable Drug Delivery Systems: Products, Therapeutics, Markets, Players and Forecasts is a comprehensive evaluation and analysis of the
technology, products and participants providing the driving force behind this evolving segment of the healthcare sector. The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, disease segments, and commercial opportunities for injectable drug delivery devices and systems that are designed for use by patients for self administration. Provider organization business managers, healthcare administrators and investors will also benefit from this study.

Converging Factors Driving the Growth of Self Administered Drug Delivery
The correlation between chronic conditions and the benefits of patient selfadministration continues to influence therapeutic product decisions, managed care
initiatives and regulatory actions. Drug injection device designs are increasingly being based on the results of human engineering inputs and patient preference research. Branding and packaging choices are more frequently being driven by data sources historically employed by consumer product marketers. For drug developers and device suppliers, the implications of these trends are influencing product development methodology and changing supply chain relationships. Decisions regarding as-supplied packaging that were once considered boilerplate have moved to the early stages of the development process. The trend toward self-administration of injectables will exert increasing influence on all aspects of the parenteral drug sector.

What You Will Learn
• What are the dynamics of the shifting landscape for self-administered injectable drug delivery and the market impact of new and evolving syringes and injectors by therapeutic indication?
• What are the market drivers influencing syringes and injectors for patient self-administration - device designs, feature/functionality, product branding, competing technologies and commercial development?
• What are the key characteristics of the major self-administered injectable device market segments and what is the impact of market demographics, and competing business strategies?
• What is the current market demand for syringes and injectors developed for patient self-administration by indication and therapy and what will it be in 2024?
• Who are the leading injection device companies, and what are their product development activities, business strategies, and corporate alliances and affiliations?
• What is the impact of economic, technology, and regulatory factors on self-administered injectable drug delivery demand?